Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
TG Therapeutics, Inc. (TGTX) had Debt to Capital Ratio of 0.55 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$240.34M |
|
$7.78M |
|
$41.19M |
|
$199.14M |
|
$218.66M |
|
$21.67M |
|
$-11.44M |
|
$10.23M |
|
$10.23M |
|
$7.78M |
|
$7.78M |
|
$7.78M |
|
$7.78M |
|
$21.67M |
|
$21.76M |
|
141.77M |
|
157.28M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$1.15B |
|
-- |
|
$493.94M |
|
$1.64B |
|
$268.49M |
|
$745.39M |
|
$767.05M |
|
$1.04B |
|
$604.08M |
|
$604.08M |
|
$604.08M |
|
153.08M |
|
| Cash Flow Statement Financials | |
$21.37M |
|
$-8.83M |
|
$390.91M |
|
$80.49M |
|
$483.94M |
|
$403.45M |
|
$47.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.27 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.55 |
1.23 |
|
82.86% |
|
9.02% |
|
9.02% |
|
-- |
|
4.26% |
|
3.24% |
|
$21.02M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.28 |
|
0.60 |
|
150.38 |
|
1.29% |
|
1.29% |
|
0.47% |
|
0.58% |
|
$3.95 |
|
$0.13 |
|
$0.14 |
|